Last reviewed · How we verify

NCT00532766

Bioequivalence of Jusline Following Subcutaneous Administration in Healthy Subjects

Completed NA Last updated 24 September 2007
What this trial tests

NA trial testing Jusline in Healthy in 20 participants. Completed in 1 February 2007.

Timeline
1 November 2006
1 February 2007

Quick facts

Lead sponsorKing Saud University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment20
Start date1 November 2006
Estimated completion1 February 2007
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

King Saud University

Who can join

Adults 18 to 35, male only, with Healthy. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

To evaluate the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline) after subcutaneous administration, and to compare this profile with Humulin insulin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other King Saud University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00532766.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing